Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

作者信息

Savelieva Irina, Camm John

出版信息

Am Heart J. 2007 Sep;154(3):403-6. doi: 10.1016/j.ahj.2007.05.008.

DOI:10.1016/j.ahj.2007.05.008

PMID:17719281

Abstract

摘要

相似文献

Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

Am Heart J. 2007 Sep;154(3):403-6. doi: 10.1016/j.ahj.2007.05.008.

Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?

Am Heart J. 2004 May;147(5):751-2. doi: 10.1016/j.ahj.2003.10.042.

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy.

Am Heart J. 2005 Mar;149(3):566. doi: 10.1016/j.ahj.2004.09.020.

Reduced atrial fibrillation incidence by angiotensin-converting enzyme inhibitors: a possible contributing mechanism.

J Am Coll Cardiol. 2005 Apr 5;45(7):1144; author reply 1144. doi: 10.1016/j.jacc.2004.12.055.

Reply to Ogimoto, angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.).

Am Heart J. 2005 Jul;150(1):e5. doi: 10.1016/j.ahj.2004.09.024.

Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

J Am Coll Cardiol. 2006 Feb 21;47(4):889; author reply 890-1. doi: 10.1016/j.jacc.2005.11.032. Epub 2006 Jan 26.

The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?

J Hum Hypertens. 2004 Jul;18(7):461-5. doi: 10.1038/sj.jhh.1001694.

Atrial fibrillation, maybe it is not so lone?

J Am Coll Cardiol. 2009 Jan 6;53(1):30-1. doi: 10.1016/j.jacc.2008.10.010.

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.

Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31.

Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.

J Am Coll Cardiol. 2006 Feb 21;47(4):889-90; author reply 890-1. doi: 10.1016/j.jacc.2005.11.033. Epub 2006 Jan 26.

引用本文的文献

Paradigm shifts in pathophysiology and management of atrial fibrillation-a tale of the RACE trials in the Netherlands.

Neth Heart J. 2020 Aug;28(Suppl 1):3-12. doi: 10.1007/s12471-020-01476-0.

Assessment of the Framingham risk factors among ED patients with newly diagnosed atrial fibrillation.

Am J Emerg Med. 2012 Jan;30(1):151-7. doi: 10.1016/j.ajem.2010.11.018. Epub 2011 Jan 3.

Novel pharmacological approaches for antiarrhythmic therapy.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Mar;381(3):187-93. doi: 10.1007/s00210-009-0487-8. Epub 2010 Jan 15.

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Mar;381(3):1-13. doi: 10.1007/s00210-009-0468-y. Epub 2009 Nov 25.

Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.

Am J Hypertens. 2009 May;22(5):538-44. doi: 10.1038/ajh.2009.33. Epub 2009 Mar 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验